Safety, Tolerability and Efficacy of Single Dose Low Cost Minipool Intravenous Immunoglobulins in Moderately Severe Newly Diagnosed ITP

NCT02669277 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Pediatric ITP

Interventions

DRUG: IVIG prepared by minipool technology
DRUG: standard IVIG product

Sponsor

Ain Shams University